Literature DB >> 6852633

Defective release of C5a related chemo-attractant activity from complement in Crohn's disease.

J Elmgreen, A Berkowicz, H Sørensen.   

Abstract

Complement was studied in 20 untreated cases of Crohn's disease and in 20 healthy volunteers by an in vitro activation of the cascade reaction. Total haemolytic complement was normal in all patients. In contrast, activation of the alternative pathway lead to a decreased release of C5a related chemo-attractant activity together with a subnormal utilisation of the main complement component C3. This abnormality of complement function was not related to the activity of the disease, site of involvement or to disease duration. The results suggest that an inadequate stimulation of important neutrophil functions may result when bacterial lipopolysaccharides and other macromolecules activating the alternative pathway penetrate the gut mucosa. A delayed clearance from the tissue of such foreign material could be a further pathogenic factor in Crohn's disease leading to granulomatous inflammation by a foreign body reaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852633      PMCID: PMC1420010          DOI: 10.1136/gut.24.6.525

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  The nitroblue tetrazolium test in Crohn's disease and ulcerative colitis.

Authors:  M Ward; M A Eastwood
Journal:  Digestion       Date:  1976       Impact factor: 3.216

Review 2.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.

Authors:  R O Webster; S R Hong; R B Johnston; P M Henson
Journal:  Immunopharmacology       Date:  1980-06

5.  Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis.

Authors:  D E Hammerschmidt; P R Craddock; F McCullough; R S Kronenberg; A P Dalmasso; H S Jacob
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

6.  Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.

Authors:  C O Moráin; A A Segal; D Walker; A J Levi
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

7.  Defective neutrophil migration in sarcoidosis.

Authors:  R W Gange; M M Black; P Carrington; R McKerron
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

8.  Inhibition of leucocyte motility by drugs used in ulcerative colitis.

Authors:  J M Rhodes; T C Bartholomew; D P Jewell
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

9.  In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.

Authors:  R D'Amelio; P Rossi; S Le Moli; R Ricci; S Montano; F Pallone
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

10.  Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.

Authors:  H Nielsen; P H Petersen; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

View more
  5 in total

1.  Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.

Authors:  J Elmgreen; H Both; V Binder
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

Review 2.  The aetiology of Crohn's disease.

Authors:  G N Tytgat; C J Mulder
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

3.  Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.

Authors:  J Elmgreen
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.

Authors:  J Elmgreen; T M Hansen
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

5.  High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.

Authors:  László Bene; George Füst; Béla Fekete; Agota Kovács; Laura Horváth; Zoltán Prohászka; Kata Miklós; Gábor Pálos; Mohamed Daha; Henriette Farkas; Lilian Varga
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.